CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Nakae R, Matsuzaki S, Serada S, Matsuo K, et al. Am J Obstet Gynecol 2020 Aug 18. pii: S0002-9378(20)30856.

Read + Share

Amedeo Smart

Independent Medical Education

Nakae R, Matsuzaki S, Serada S, Matsuo K, et al. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Am J Obstet Gynecol 2020 Aug 18. pii: S0002-9378(20)30856.
PMID: 32822640